Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
These dynamics can rattle even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. Keeping that in mind, here are two mid-cap stocks with long growth runways and one best left ignored.
One Mid-Cap Stock to Sell:
UL Solutions (ULS)
Market Cap: $14.11 billion
Founded in 1894 as a response to the growing dangers of electricity in American homes and businesses, UL Solutions (NYSE: ULS) provides testing, inspection, and certification services that help companies ensure their products meet safety, security, and sustainability standards.
Why Does ULS Fall Short?
- 4.3% annual revenue growth over the last three years was slower than its business services peers
At $70.38 per share, UL Solutions trades at 40.2x forward P/E. Read our free research report to see why you should think twice about including ULS in your portfolio.
Two Mid-Cap Stocks to Watch:
ITT (ITT)
Market Cap: $11.97 billion
Playing a crucial role in the development of the first transatlantic television transmission in 1956, ITT (NYSE: ITT) provides motion and fluid handling equipment for various industries
Why Do We Watch ITT?
- Operating margin expanded by 9.6 percentage points over the last five years as it scaled and became more efficient
- Share repurchases over the last two years enabled its annual earnings per share growth of 13.9% to outpace its revenue gains
- ROIC punches in at 17.5%, illustrating management’s expertise in identifying profitable investments, and its returns are climbing as it finds even more attractive growth opportunities
ITT’s stock price of $152.15 implies a valuation ratio of 23.3x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.
Molina Healthcare (MOH)
Market Cap: $15.91 billion
Founded in 1980 as a provider for underserved communities in Southern California, Molina Healthcare (NYSE: MOH) provides managed healthcare services primarily to low-income individuals through Medicaid, Medicare, and Marketplace insurance programs across 21 states.
Why Should You Buy MOH?
- Annual revenue growth of 19.4% over the past five years was outstanding, reflecting market share gains this cycle
- Large revenue base of $41.87 billion gives it power over healthcare providers and plan holders
- Earnings growth has trumped its peers over the last five years as its EPS has compounded at 14.6% annually
Molina Healthcare is trading at $293.48 per share, or 11.4x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today.
